Flash deal
Buy 1 get 1 free
Ends in
0Days00Hours00Mins
Time left74%

Cardarine GW-501516 - 100 Tablets

In stock

Lab tested · Dec 2025
£49.95
Buy 1 get 1 free Mix and match. The cheaper one is free.
Until Mon 23 Nov, 19:00 or while the amount lasts. Pairs aren't part of 3 for 2.

Buy 1 get 1 free

Decline Buy 1 get 1 free deal

A pouch of 100 Cardarine (GW-501516) tablets, 10mg per tablet. Although it is sold alongside SARMs, GW-501516 does not act on the androgen receptor. It is a selective PPARδ agonist, originally a GlaxoSmithKline and Ligand Pharmaceuticals drug candidate, and is used in laboratory research on lipid and energy metabolism.

Supplied for Research Purposes Only This information and product is provided for research purposes only. We do not provide any advice on the usage of these products. These products are for sale to persons aged 18 and over only. Customers should check the legality of this product in their own country prior to purchase.

Certificate of analysis

Independently tested by MZ Biolabs

All lab reports
View full certificate from 10 December 2025 (PDF, opens in a new tab)

Latest result

Most recent test
  • 99% Of expected amount 9.9 mg measured, 10 mg expected
Sample tested
Finished product
Analysis date
10 December 2025
Laboratory
MZ Biolabs
Lab lot
2025-11-21
Identity
Molecular weight confirmed
Method
HPLC-UV-MS

Testing history

  1. 10 December 2025 99% of expected · Finished product PDF
  2. 7 March 2023 Purity 99.71% PDF
  3. 20 February 2022 Purity 100% PDF
  4. 21 May 2021 Purity 100% PDF

GW-501516, the PPARδ agonist better known as Cardarine

A receptor agonist, not a SARM

Cardarine is usually listed with SARMs, but it belongs to a different pharmacological class. Its target is PPARδ (peroxisome proliferator-activated receptor delta), a nuclear receptor that controls genes involved in fatty acid oxidation and energy use in tissues such as skeletal muscle. GW-501516 binds PPARδ with high selectivity over the related receptors PPARα and PPARγ, which is why it became the standard tool compound for this receptor.

From drug candidate to research tool

The compound came out of a 1990s collaboration between GlaxoSmithKline and Ligand Pharmaceuticals and entered clinical trials as a candidate for metabolic and cardiovascular conditions. GSK ended development in 2007 after long-term rodent studies raised safety concerns, and it has never been licensed as a medicine. Since then it has been used in cell culture and rodent experiments that ask what PPARδ does: work on muscle fibre type, lipid handling and mouse running models are the best-known examples.

What you receive

Each pouch holds 100 tablets under the Dynamic Performance label, and each tablet contains 10mg of Cardarine GW-501516. Store the pouch closed, somewhere cool and dry, away from sunlight. The tablets are intended as a reference material for in vitro work and analytical method development, and are not a medicine or a food supplement.

Also listed as

  • GW501516

Products are supplied for research purposes only and are for sale to persons aged 18 and over.